Select for export Investigating changes in EEG entropy rate in response to psilocybin - a comparison of lempel ziv and state-space entropy rate measures No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2023.103667 Copy citation Copy BibTeX Neuroscience Applied 2022-12-31 M. Nikolič, P. Mediano, Tom Froese, Tomáš Páleníček OpenAlex Published psilocybin Brain Imaging Other More
Select for export Visualizing drug actions on dendrites: psilocybin and other classic psychedelics Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1364/brain.2023.btu2b.2 Copy citation Copy BibTeX Unknown journal 2022-12-31 Ling-Xiao Shao, Clara Liao, Ian Gregg, Pasha A. Davoudian, Neil K. Savalia, Kristina Delagarza OpenAlex Published psilocybin Receptor PharmacologyAnimal Study Animal Study More
Select for export Italian psychedelic therapies of the past century: An historical overview Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/20503245231179687 Copy citation Copy BibTeX Drug Science Policy and Law 2022-12-31 Adriana D’Arienzo, Giorgio Samorini OpenAlex Published psilocybin DepressionReceptor Pharmacology Other More
Select for export Going on Trial: Serotonin drug; psilocybin phase 2; placebo response data Abstract available at the source but not redistributed here. Read at source. Details DOI 10.53053/etcr6498 Copy citation Copy BibTeX The Transmitter 2022-12-31 Peter Hess OpenAlex Published psilocybin PharmacologyReceptor PharmacologyClinical Trial Clinical Trial More
Select for export Company on brink takes psilocybin to trial for fragile X syndrome No abstract availability was recorded for this entry. Details DOI 10.53053/mkkk7368 Copy citation Copy BibTeX The Transmitter 2022-12-31 Peter Hess OpenAlex Published psilocybin General Other More
Select for export Therapeutic mechanism of psilocybin in the treatment of depression and other psychiatric disorders. No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2023.101067 Copy citation Copy BibTeX Neuroscience Applied 2022-12-31 O. Shahar, A. Botvinik, T. Lifschytz, B. Lerer OpenAlex Published psilocybin Depression Other More
Select for export Going on Trial: Arbaclofen reboot; cell implants; psilocybin microdoses Abstract available at the source but not redistributed here. Read at source. Details DOI 10.53053/nbdr8957 Copy citation Copy BibTeX The Transmitter 2022-12-31 Peter Hess OpenAlex Published psilocybin MicrodosingClinical Trial Clinical Trial More
Select for export Ego Birth: Measure 109, The NMHA, and Forward Movement in the Nascent Psilocybin Industry No abstract availability was recorded for this entry. Details DOI 10.2139/ssrn.4459584 Copy citation Copy BibTeX SSRN Electronic Journal 2022-12-31 Andrew M. Robie OpenAlex Published psilocybin General Other More
Select for export Psychedelic Drug Therapy for Mental Disorders? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.4236/ojmp.2023.123010 Copy citation Copy BibTeX Open Journal of Medical Psychology 2022-12-31 John R. Rossiter OpenAlex Published psilocybin DepressionPTSDAddiction Clinical Trial More
Select for export Psilocybin as a treatment for anorexia nervosa: 6-week and 3-month follow-up results No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2023.102878 Copy citation Copy BibTeX Neuroscience Applied 2022-12-31 Hannah Douglass, Merle Spriggs, Kate Godfrey, Jennifer L. Danby, Francisco Magalhães, Kirsty L. Alderton OpenAlex Published psilocybin Eating Disorders Other More
Select for export A roadmap for psychedelic pharmacy in Canada: A proposed policy and operations approach for controlled access to select psychedelics for treatment of mental illness Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/20503245231170340 Copy citation Copy BibTeX Drug Science Policy and Law 2022-12-31 Jaden Brandt OpenAlex Published psilocybin Toxicity Other More
Select for export Case report: Prolonged amelioration of mild red-green color vision deficiency following psilocybin mushroom use Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/20503245231172536 Copy citation Copy BibTeX Drug Science Policy and Law 2022-12-31 Brian S. Barnett, Noah Wiles Sweat, Peter S. Hendricks OpenAlex Published psilocybin AddictionMechanism of ActionCase Report Case Report More
Select for export From prohibited to prescribed: The rescheduling of MDMA and psilocybin in Australia No abstract availability was recorded for this entry. Details DOI 10.1177/20503245231198472 Copy citation Copy BibTeX Drug Science Policy and Law 2022-12-31 Octavian Dixon Ritchie, Cameron N Donley, Gabrielle Dixon Ritchie OpenAlex Published psilocybin Toxicity Other More
Select for export Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221140004 PubMed 36588452 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-12-31 Jack E. Henningfield, Judy Ashworth, David J. Heal, Sharon L. Smith OpenAlex Published psilocybin PharmacologyMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221146356 PubMed 36601974 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-12-31 Matthias Forstmann, Hannes Kettner, Christina Sagioglou, Alexander Irvine, Sam Gandy, Robin Carhart-Harris OpenAlex Published psilocybin AddictionPharmacologyToxicity Other More
Select for export The Resurgence of Hallucinogen Drugs in Clinical Research. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.24875/ric.23000108 PubMed 37441761 Copy citation Copy BibTeX Unknown journal 2022-12-31 Rivera-García MT, Cruz SL. Europe PMC Published psilocin Receptor PharmacologyReview ArticleAnimal Study Review Article More
Select for export Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1353/pbm.2023.0007 PubMed 38662012 Copy citation Copy BibTeX Perspectives in biology and medicine 2022-12-31 Gail A. Edelsohn, Dominic Sisti OpenAlex Published psilocybin DepressionPTSDAddiction Clinical Trial More
Select for export On blinding and suicide risk in a recent trial of psilocybin-assisted therapy for treatment-resistant depression No abstract availability was recorded for this entry. Details DOI 10.1016/j.medj.2022.12.003 PubMed 36640755 Copy citation Copy BibTeX Med 2022-12-31 Natalie Gukasyan OpenAlex Published psilocybin DepressionClinical TrialTreatment-Resistant Depression Clinical Trial More
Select for export Mini-review: The neurobiology of treating substance use disorders with classical psychedelics. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fnins.2023.1156319 PubMed 37139521 Copy citation Copy BibTeX Frontiers in neuroscience 2022-12-31 Urban MM, Stingl MR, Meinhardt MW PubMed Published psilocybin AddictionNeuroplasticityMechanism of Action Review Article More
Select for export Psilocybin for Depression: From Credibility to Feasibility, What’s Missing? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/ph16010068 PubMed 36678564 Copy citation Copy BibTeX Pharmaceuticals 2022-12-30 Antonio Munafò, Davide Arillotta, Guido Mannaioni, Fabrizio Schifano, Renato Bernardini, Giuseppina Cantarella OpenAlex Published psilocybin Depression Other More
